Boulkeroua Chahrazed, Ayari Houda, Khalfaoui Taoufik, Lafrance Mylène, Besserer-Offroy Élie, Ekindi Nadia, Sabbagh Robert, Dumaine Robert, Lesur Olivier, Sarret Philippe, Chraibi Ahmed
Department of Pharmacology & Physiology, Faculty of Medicine and Health Sciences, Sherbrooke University, Sherbrooke, QC, Canada.
Department of Pathology, Faculty of Medicine and Health Sciences, Sherbrooke University, Sherbrooke, QC, Canada.
Cell Physiol Biochem. 2019;53(4):687-700. doi: 10.33594/000000165.
BACKGROUND/AIMS: Apelin and its G protein-coupled receptor APJ (gene symbol Aplnr) are strongly expressed in magnocellular vasopressinergic neurons suggesting that the apelin/APJ system plays a key role at the central level in regulating salt and water balance by counteracting the antiduretic action of vasopressin (AVP). Likewise, recent studies revealed that apelin exerts opposite effects to those of vasopressin induced on water reabsorption via a direct action on the kidney collecting duct. However, the underlying mechanisms of the peripheral action of apelin are not clearly understood. Here, we thus investigated the role of the apelin/APJ system in the regulation of water balance in the kidney, and more specifically its involvement in modulating the function of aquaporin-2 (AQP2) in the collecting duct.
Mouse cortical collecting duct cells (mpkCCD) were incubated in the presence of dDAVP and treated with or without apelin-13. Changes in AQP2 expression and localization were determined by immunoblotting and confocal immunofluorescence staining.
Herein, we showed that the APJ was present in mpkCCD cells. Treatment of mpkCCD with apelin-13 reduced the cAMP production and antagonized the AVP-induced increase in AQP2 mRNA and protein expressions. Immunofluorescent experiments also revealed that the AVP-induced apical cell surface expression of AQP2, and notably its phosphorylated isoform AQP2-pS269, was considerably reduced following apelin-13 application to mpkCCD cells.
Our data reinforce the aquaretic role of the apelin/APJ system in the fine regulation of body fluid homeostasis at the kidney level and its physiological opposite action to the antiduretic activity of AVP.
背景/目的:阿片肽及其G蛋白偶联受体APJ(基因符号Aplnr)在大细胞血管加压素能神经元中强烈表达,这表明阿片肽/APJ系统在中枢水平通过对抗血管加压素(AVP)的抗利尿作用在调节盐和水平衡中起关键作用。同样,最近的研究表明,阿片肽通过对肾集合管的直接作用,对AVP诱导的水重吸收产生相反的作用。然而,阿片肽外周作用的潜在机制尚不清楚。因此,我们在此研究了阿片肽/APJ系统在肾脏水平调节水平衡中的作用,更具体地说,其参与调节集合管中水通道蛋白-2(AQP2)的功能。
将小鼠皮质集合管细胞(mpkCCD)在去氨加压素(dDAVP)存在下孵育,并分别用或不用阿片肽-13处理。通过免疫印迹和共聚焦免疫荧光染色确定AQP2表达和定位的变化。
在此,我们表明APJ存在于mpkCCD细胞中。用阿片肽-13处理mpkCCD可降低cAMP的产生,并拮抗AVP诱导的AQP2 mRNA和蛋白表达增加。免疫荧光实验还显示,在mpkCCD细胞中应用阿片肽-13后,AVP诱导的AQP2在顶端细胞表面的表达,特别是其磷酸化异构体AQP2-pS269,显著降低。
我们的数据强化了阿片肽/APJ系统在肾脏水平对体液稳态精细调节中的利水作用及其与AVP抗利尿活性的生理相反作用。